{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:45:08Z","timestamp":1784555108539,"version":"3.55.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"he National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82341031, 82173584, and 82222062"],"award-info":[{"award-number":["82341031, 82173584, and 82222062"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangsu Provincial Science Fund for Distinguished Young Scholars","award":["BK20220064"],"award-info":[{"award-number":["BK20220064"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11140-w","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T03:13:13Z","timestamp":1748142793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunogenicity and safety of a booster dose of the COVID-19 DNA vaccine in healthy adults aged 18 years and above: a single-center, randomized, observer-blind, placebo-controlled phase 2 trial"],"prefix":"10.1186","volume":"25","author":[{"given":"Aihua","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyue","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefen","family":"Huai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danjing","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,25]]},"reference":[{"issue":"41","key":"11140_CR1","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.1016\/j.vaccine.2017.02.015","volume":"35","author":"Maslow J N","year":"2017","unstructured":"Maslow J N. Vaccine development for emerging virulent infectious diseases[J]. Vaccine. 2017;35(41):5437\u201343. https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.015.","journal-title":"Vaccine"},{"issue":"3","key":"11140_CR2","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/infdis\/jiz132","volume":"220","author":"P Tebas","year":"2019","unstructured":"Tebas P, Kraynyak K A, Patel A, et al. Intradermal SynCon\u00ae Ebola GP DNA vaccine is temperature stable and safely demonstrates cellular and humoral immunogenicity advantages in healthy Volunteers[J]. J Infect Dis. 2019;220(3):400\u201310. https:\/\/doi.org\/10.1093\/infdis\/jiz132.","journal-title":"J Infect Dis"},{"issue":"9","key":"11140_CR3","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S1473-3099(19)30266-X","volume":"19","author":"K Modjarrad","year":"2019","unstructured":"Modjarrad K, Roberts C C, Mills K T, et al. Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial[J]. Lancet Infect Dis. 2019;19(9):1013\u201322. https:\/\/doi.org\/10.1016\/S1473-3099(19)30266-X.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"11140_CR4","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1038\/s41467-020-16505-0","volume":"11","author":"A Smith T R F, Patel","year":"2020","unstructured":"Smith T R F, Patel A, Ramos S, et al. Immunogenicity of a DNA vaccine candidate for COVID-19[J]. Nat Commun. 2020;11(1):2601. https:\/\/doi.org\/10.1038\/s41467-020-16505-0.","journal-title":"Nat Commun"},{"issue":"21","key":"11140_CR5","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1016\/j.vaccine.2022.03.060","volume":"40","author":"JN Walters","year":"2022","unstructured":"Walters JN, Patel Schouestb. Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates[J]. Vaccine. 2022;40(21):2960\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2022.03.060.","journal-title":"Vaccine"},{"issue":"11","key":"11140_CR6","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1093\/infdis\/jiac016","volume":"225","author":"E Kraynyak K A, Blackwood","year":"2022","unstructured":"Kraynyak K A, Blackwood E, Agnes J, et al. Sars-CoV-2 DNA vaccine INO-4800 induces durable immune responses capable of being boosted in a phase 1 Open-Label Trial[J]. J Infect Dis. 2022;225(11):1923\u201332. https:\/\/doi.org\/10.1093\/infdis\/jiac016.","journal-title":"J Infect Dis"},{"key":"11140_CR7","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2448405","author":"SY JIA","year":"2024","unstructured":"JIA SY, Shao CW, CHENG X, et al. Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: a randomized, observer-blind, placebo-controlled phase 2 trial[J]. Hum Vaccines Immunotherapeutics. 2024. https:\/\/doi.org\/10.1080\/21645515.2024.2448405.","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"12","key":"11140_CR8","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1056\/NEJMoa1708120","volume":"385","author":"P Tebas","year":"2021","unstructured":"Tebas P, Roberts C C, Muthumani K, et al. ZIKA-001: safety and immunogenicity of an engineered DNA vaccine against Zika virus infection[J]. N Engl J Med. 2021;385(12):e35. https:\/\/doi.org\/10.1056\/NEJMoa1708120.","journal-title":"N Engl J Med"},{"key":"11140_CR9","unstructured":"NMPA Issued the Guidelines for Adverse Event Classification Standards for Clinical Trials of Preventive Vaccines[EB\/OL]. [2024-11-28]. https:\/\/english.nmpa.gov.cn\/2019-12\/31\/c_448385.htm"},{"issue":"10332","key":"11140_CR10","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/S0140-6736(22)00151-9","volume":"399","author":"A Khobragade","year":"2022","unstructured":"Khobragade A, Bhate S. Efficacy, safety, and immunogenicity of the DNA Sars-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India[J]. Lancet (London England). 2022;399(10332):1313\u201321. https:\/\/doi.org\/10.1016\/S0140-6736(22)00151-9.","journal-title":"Lancet (London England)"},{"issue":"3","key":"11140_CR11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000343475","volume":"59","author":"Prelog M","year":"2013","unstructured":"Prelog M. Differential approaches for vaccination from childhood to old age[J]. Gerontology. 2013;59(3):230\u20139. https:\/\/doi.org\/10.1159\/000343475.","journal-title":"Gerontology"},{"key":"11140_CR12","doi-asserted-by":"publisher","unstructured":"Mahase E. Covid-19: longer interval between Pfizer doses results in higher antibody levels, research finds[J]. BMJ (Clinical Res ed.), 2021, 374: n1875. https:\/\/doi.org\/10.1136\/bmj.n1875","DOI":"10.1136\/bmj.n1875"},{"key":"11140_CR13","doi-asserted-by":"publisher","unstructured":"Atmar RL, Lyke K E, Deming M E et al. Heterologous Sars-CoV-2 Booster Vaccinations\u2013 Preliminary Report[J]. medRxiv, 2021: 2021.https:\/\/doi.org\/10.1101\/2021.10.10.21264827","DOI":"10.1101\/2021.10.10.21264827"},{"issue":"2","key":"11140_CR14","doi-asserted-by":"publisher","first-page":"e13097","DOI":"10.1111\/irv.13097","volume":"17","author":"Z WEI","year":"2023","unstructured":"WEI Z, Wang MAW. Household transmission of Sars-CoV-2 during the Omicron wave in Shanghai, China: A case-ascertained study[J]. Influenza Other Respir Viruses. 2023;17(2):e13097. https:\/\/doi.org\/10.1111\/irv.13097.","journal-title":"Influenza Other Respir Viruses"},{"key":"11140_CR15","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.3389\/fimmu.2019.01787","volume":"10","author":"Henryc Palm A K E","year":"2019","unstructured":"Palm A K E Henrycenryc. Remembrance of things past: Long-Term B cell memory after infection and Vaccination[J]. Front Immunol. 2019;10:1787. https:\/\/doi.org\/10.3389\/fimmu.2019.01787.","journal-title":"Front Immunol"},{"issue":"4","key":"11140_CR16","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.immuni.2010.10.008","volume":"33","author":"F Sallusto","year":"2010","unstructured":"Sallusto F, Lanzavecchia A, Araki K, et al. From vaccines to memory and back[J\/OL]. Immunity. 2010;33(4):451\u201363. https:\/\/doi.org\/10.1016\/j.immuni.2010.10.008.","journal-title":"Immunity"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11140-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11140-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11140-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T03:13:15Z","timestamp":1748142795000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11140-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,25]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11140"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11140-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,25]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This booster study was reviewed and approved by the Research Ethics Committee of the Jiangsu Provincial Center for Disease Control and Prevention (ref: JSJK2021-A034-02). All patients provided fully informed written consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients had provided informed consent for the participants in the study and publication of any associated data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"750"}}